Search research articles
Contact Us
Filters
Showing results (121-130 of 220) with videos related to
Page
of 22
Sort By:
Frontiers in Behavioral Neuroscience
|
October 7, 2015
The down syndrome biomarker initiative (DSBI) pilot: proof of concept for deep phenotyping of Alzheimer's disease biomarkers in down syndrome
Michael S Rafii, Hannah Wishnek, James B Brewer, et al.
The Journal of Prevention of Alzheimer'S Disease
|
July 9, 2025
CTAD taskforce: genetic therapies in Alzheimer's disease
D Jakabek, A M Isaacs, B De Strooper, et al.
Andrology
|
June 7, 2014
Evaluation of candidate spermatogonial markers ID4 and GPR125 in testes of adult human cadaveric organ donors
C Sachs, B D Robinson, L Andres Martin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
June 28, 2024
Assessing amyloid PET positivity and cognitive function in Down syndrome to guide clinical trials targeting amyloid
Sophia Krasny, Cynthia Yan, Sigan L Hartley, et al.
JAMA Neurology
|
March 28, 2018
Adeno-Associated Viral Vector (Serotype 2)-Nerve Growth Factor for Patients With Alzheimer Disease: A Randomized Clinical Trial
Michael S Rafii, Mark H Tuszynski, Ronald G Thomas, et al.
Blood
|
December 10, 1999
Stromal derived factor-1-induced chemokinesis of cord blood CD34(+) cells (long-term culture-initiating cells) through endothelial cells is mediated by E-selectin
A J Naiyer, D Y Jo, J Ahn, et al.
Journal of Neuropathology and Experimental Neurology
|
October 29, 2024
Clinical and neuropathological analysis of Down syndrome over 7 decades of life
Sonal Sukreet, Vanessa S Goodwill, Jennifer Ngolab, et al.
Experimental Hematology
|
December 26, 2001
Anagrelide metabolite induces thrombocytopenia in mice by inhibiting megakaryocyte maturation without inducing platelet aggregation
W J Lane, K Hattori, S Dias, et al.
Nature Reviews. Disease Primers
|
February 8, 2020
Down syndrome
Stylianos E Antonarakis, Brian G Skotko, Michael S Rafii, et al.
The Journal of Prevention of Alzheimer'S Disease
|
July 24, 2024
Safety Profile of a Cognitively Unimpaired Older Population with Elevated Cerebral Amyloid in a 4.5-Year Clinical Trial
R Yaari, K C Holdridge, M Mancini, et al.
Page
of 22
Search research articles
Search
Showing results (121-130 of 220) with videos related to
Sort By:
Page
of 22
Frontiers in Behavioral Neuroscience
|
October 7, 2015
The down syndrome biomarker initiative (DSBI) pilot: proof of concept for deep phenotyping of Alzheimer's disease biomarkers in down syndrome
Michael S Rafii, Hannah Wishnek, James B Brewer, et al.
The Journal of Prevention of Alzheimer'S Disease
|
July 9, 2025
CTAD taskforce: genetic therapies in Alzheimer's disease
D Jakabek, A M Isaacs, B De Strooper, et al.
Andrology
|
June 7, 2014
Evaluation of candidate spermatogonial markers ID4 and GPR125 in testes of adult human cadaveric organ donors
C Sachs, B D Robinson, L Andres Martin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
June 28, 2024
Assessing amyloid PET positivity and cognitive function in Down syndrome to guide clinical trials targeting amyloid
Sophia Krasny, Cynthia Yan, Sigan L Hartley, et al.
JAMA Neurology
|
March 28, 2018
Adeno-Associated Viral Vector (Serotype 2)-Nerve Growth Factor for Patients With Alzheimer Disease: A Randomized Clinical Trial
Michael S Rafii, Mark H Tuszynski, Ronald G Thomas, et al.
Blood
|
December 10, 1999
Stromal derived factor-1-induced chemokinesis of cord blood CD34(+) cells (long-term culture-initiating cells) through endothelial cells is mediated by E-selectin
A J Naiyer, D Y Jo, J Ahn, et al.
Journal of Neuropathology and Experimental Neurology
|
October 29, 2024
Clinical and neuropathological analysis of Down syndrome over 7 decades of life
Sonal Sukreet, Vanessa S Goodwill, Jennifer Ngolab, et al.
Experimental Hematology
|
December 26, 2001
Anagrelide metabolite induces thrombocytopenia in mice by inhibiting megakaryocyte maturation without inducing platelet aggregation
W J Lane, K Hattori, S Dias, et al.
Nature Reviews. Disease Primers
|
February 8, 2020
Down syndrome
Stylianos E Antonarakis, Brian G Skotko, Michael S Rafii, et al.
The Journal of Prevention of Alzheimer'S Disease
|
July 24, 2024
Safety Profile of a Cognitively Unimpaired Older Population with Elevated Cerebral Amyloid in a 4.5-Year Clinical Trial
R Yaari, K C Holdridge, M Mancini, et al.
Page
of 22